DK0891344T3 - Antagonister til alpha-1-adrenergisk receptor - Google Patents

Antagonister til alpha-1-adrenergisk receptor

Info

Publication number
DK0891344T3
DK0891344T3 DK97919488T DK97919488T DK0891344T3 DK 0891344 T3 DK0891344 T3 DK 0891344T3 DK 97919488 T DK97919488 T DK 97919488T DK 97919488 T DK97919488 T DK 97919488T DK 0891344 T3 DK0891344 T3 DK 0891344T3
Authority
DK
Denmark
Prior art keywords
antagonists
alpha
adrenergic receptor
derivatives
alpha1
Prior art date
Application number
DK97919488T
Other languages
English (en)
Inventor
Dennis Bigg
De Lassauniere Pierre Charbier
Serge Auvin
Michel Auguet
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Application granted granted Critical
Publication of DK0891344T3 publication Critical patent/DK0891344T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
DK97919488T 1996-04-05 1997-04-04 Antagonister til alpha-1-adrenergisk receptor DK0891344T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62827696A 1996-04-05 1996-04-05
PCT/FR1997/000615 WO1997037983A1 (fr) 1996-04-05 1997-04-04 ANTAGONISTES DU RECEPTEUR α1-ADRENERGIQUE

Publications (1)

Publication Number Publication Date
DK0891344T3 true DK0891344T3 (da) 2003-04-07

Family

ID=24518205

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97919488T DK0891344T3 (da) 1996-04-05 1997-04-04 Antagonister til alpha-1-adrenergisk receptor

Country Status (15)

Country Link
US (1) US6300499B1 (da)
EP (1) EP0891344B1 (da)
JP (1) JP3845452B2 (da)
AT (1) ATE229946T1 (da)
AU (1) AU2393997A (da)
CZ (1) CZ315098A3 (da)
DE (1) DE69717978T2 (da)
DK (1) DK0891344T3 (da)
ES (1) ES2188936T3 (da)
HU (1) HUP9901680A3 (da)
IL (1) IL126411A0 (da)
NO (1) NO984631L (da)
PL (1) PL329190A1 (da)
RU (1) RU2179554C2 (da)
WO (1) WO1997037983A1 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661163A (en) * 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists
GB9819860D0 (en) 1998-09-12 1998-11-04 Zeneca Ltd Chemical compounds
CN1627946A (zh) * 2002-04-08 2005-06-15 兰贝克赛实验室有限公司 用作尿－选择性α1A肾上腺素能受体阻滞剂的羧酰亚胺衍生物
ATE354367T1 (de) * 2002-07-04 2007-03-15 Sanol Arznei Schwarz Gmbh Heteroarencarboxamide zur verwendung als dopamin- d3 liganden zur behandlung von zns-erkrankungen
DE10251170A1 (de) * 2002-10-31 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Beta-Agonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
WO2006021344A1 (en) * 2004-08-27 2006-03-02 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with alpha-1a adrenergic receptor (adra1a)
WO2013038427A1 (en) * 2011-09-12 2013-03-21 Council Of Scientific & Industrial Research ARYLATED β-DICARBOIMYL COMPOUNDS AND PROCESS FOR THE PREPARATION THEREOF
CN103288745A (zh) * 2013-06-25 2013-09-11 南方医科大学 一种2,6-二取代哒嗪酮类化合物及其应用
CN103304486A (zh) * 2013-06-25 2013-09-18 南方医科大学 6-（4-芳基哌嗪-1-基）哒嗪-3（2h）-酮及其应用
WO2015029447A1 (ja) * 2013-08-30 2015-03-05 興和株式会社 光学活性カルビノール化合物の製造方法
CN115124415A (zh) * 2022-06-20 2022-09-30 西咸新区行易先进材料科技有限公司 一种合成阿卓乳酸的催化反应方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2722529A (en) * 1955-11-01 Amides of certain l-amevoalkyl-x-phenyl
US2833770A (en) * 1958-05-06 Chj-chj
NL8005133A (nl) * 1980-09-12 1982-04-01 Duphar Int Res Fenylpiperazinederivaten met antiagressieve werking.
IL90279A (en) 1988-05-24 1995-03-30 American Home Prod Piperazinyl carboxamide derivatives, their preparation and pharmaceutical com¦ositions containing them
FI93832C (fi) * 1989-04-22 1995-06-12 Wyeth John & Brother Ltd Menetelmä terapeuttisesti aktiivisten piperatsiniijohdannaisten valmistamiseksi
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
DE4121276C2 (de) 1991-06-27 1994-02-17 Metallgesellschaft Ag Verfahren zur Herstellung sulfathaltiger, basischer Polyaluminiumchlorid-Lösungen
GB9200293D0 (en) 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
SE9201138D0 (sv) * 1992-04-09 1992-04-09 Astra Ab Novel phthalimidoalkylpiperazines
US5284990A (en) 1992-07-16 1994-02-08 Stratco, Inc. Method for converting a hydrogen fluoride alkylation unit to a sulfuric acid alkylation unit
US5349844A (en) 1992-09-11 1994-09-27 Trc Companies, Inc. System and method for resonant filter mass monitoring
SE9300295D0 (sv) 1993-01-28 1993-01-28 Benny Carlstroem Foerfarande och anordning foer bindning av tandlagningsmaterial
CA2166100A1 (en) * 1993-06-23 1995-01-05 Richard A. Glennon Sigma receptor ligands and the use thereof
US5414585A (en) 1993-07-19 1995-05-09 Quantum Corp. Rotating tape edge guide
IT1266582B1 (it) * 1993-07-30 1997-01-09 Recordati Chem Pharm Derivati (di)azacicloesanici e diazacicloeptanici
US5696123A (en) * 1994-09-17 1997-12-09 Boehringer Ingelheim Kg Neurokinin antagonists

Also Published As

Publication number Publication date
CZ315098A3 (cs) 1999-04-14
US6300499B1 (en) 2001-10-09
NO984631D0 (no) 1998-10-02
IL126411A0 (en) 1999-05-09
HUP9901680A2 (hu) 1999-09-28
ATE229946T1 (de) 2003-01-15
EP0891344A1 (fr) 1999-01-20
HUP9901680A3 (en) 2000-12-28
ES2188936T3 (es) 2003-07-01
DE69717978D1 (de) 2003-01-30
JP2000508310A (ja) 2000-07-04
AU2393997A (en) 1997-10-29
WO1997037983A1 (fr) 1997-10-16
JP3845452B2 (ja) 2006-11-15
RU2179554C2 (ru) 2002-02-20
PL329190A1 (en) 1999-03-15
NO984631L (no) 1998-12-02
EP0891344B1 (fr) 2002-12-18
DE69717978T2 (de) 2003-10-02

Similar Documents

Publication Publication Date Title
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
DK0891344T3 (da) Antagonister til alpha-1-adrenergisk receptor
DK0480950T3 (da) Kombinationsterapi til profylakse for og/eller behandling af godartet prostatahypertrofi
ATE194141T1 (de) Tricyclische substituierte hexahydrobenz(e)isoindol alpha-1-adrenergische antagonisten
ES2106965T3 (es) Nuevas 4-aza-5alfa-androstan-3-onas 7beta-sustituidas como inhibidores de 5alfa-reductasa.
BR9811099A (pt) Inibidores de urocinase
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
DK1112067T3 (da) Anvendelse af acetylcholinesteraseinhibitorer til fremstilling af farmaceutiske præparater til behandling af funktionelle og/eller organiske smertesyndromer
ZA986673B (en) Use of a combination of an inhibitor of converting enzyme and a diuretic for treating microcirculatory disorders
DK0805812T3 (da) Bicyklisk substitueret hexahydrobenz[e]isoindol som alfa-1-adrenerge antagonister
AU2443184A (en) Benzazocinones and benzazoninones
EP0646007A4 (da)
ES2060818T3 (es) Derivados de indol, benzofurano y benzotiofeno sustituidos como inhibidores de la 5-lipooxigenasa.
DK0874625T3 (da) Indanderivater til antipsykotiske præparater
BG103553A (en) Benzopyranopyrol and benzopyranopyridine alpha-1 adrenergic compounds
EA199900914A1 (ru) Лечение или профилактика рака простаты и доброкачественной гиперплазии простаты селективными модуляторами рецепторов эстрогена
NO20002408L (no) 5-HT1F antagonister
AU9128998A (en) Composition and method for the treatment of benign prostatic hyperplasia and prostatitis
MX9301939A (es) Composicion farmaceutica que comprende un compuesto inhibidor de 5-ó-reductasa esteroidal.
PT950056E (pt) N-(piridinilamino) isoindolinas e compostos relacionados
TR199701613T1 (xx) Selim prostatik hiperplasyan�n tedavisi i�in melatonin agonistleri.
NZ333506A (en) Methanesulphonate salt of an arylpiperazine derived from tryptamine and its solvates for pharmaceutical use
CA2251016A1 (fr) Antagonistes du recepteur .alpha.1-adrenergique
TW343129B (en) Indole derivative and rooting inducing agent containing the same as effective component
AU6374798A (en) Methods and compositions of (+) doxazosin for the treatment of hypertension and benign prostatic hyperplasia